Healthcare costs of Staphylococcus aureus and Clostridium difficile infections in Veterans: Role of vitamin D deficiency

Epidemiology and Infection

Volumn 138, Issue 9, 2010, Pages 1322-1327

  Youssef, D ^a,b   Bailey, B ^b   El Abbassi, A ^a,b   Copeland, R ^b   Adebonojo, L ^a   Manning, T ^a   Peiris, A N ^a,b  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b East Tennessee State University   (United States)

Author keywords

Clostridium difficile; health costs; public health; Staphylococcus aureus; vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CONSULTATION; CONTROLLED STUDY; COST OF ILLNESS; FEMALE; HEALTH CARE COST; HOSPITAL PATIENT; HOSPITALIZATION COST; HUMAN; LABORATORY TEST; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; OUTPATIENT CARE; STAPHYLOCOCCUS INFECTION; VETERAN; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; CHI SQUARE DISTRIBUTION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTION; ECONOMICS; HOSPITALIZATION; MIDDLE AGED; STAPHYLOCOCCUS AUREUS; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TENNESSEE; VETERANS; VITAMIN D DEFICIENCY;

EID: 77956635116     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809991543     Document Type: Article

References (36)

1. Holick MF. The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Molecular Aspects of Medicine 2008;29:361-368.
2. Bikle DD. Vitamin D and the immune system: role in protection against bacterial infection. Current Opinion in Nephrology and Hypertension 2008;17:348-352.
3. Feindt E, Ströder J. Studies on the antimicrobial effect of vitamin D. Wiener Klinische Wochenschrift 1977;55:507-508.
4. Roth DE, et al. Vitamin D receptor polymorphisms and the risk of acute lower respiratory tract infection in early childhood. Journal of Infectious Diseases 2008;197:676-680.
5. Karatekin G, et al. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. European Journal of Clinical Nutrition 2009;63:473-477.
6. De la Torre MS, et al. Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users. Journal of Infectious Diseases 2008;197:405-410.
7. Li JH, et al. Study on association between vitamin D receptor gene polymorphisms and the outcomes of HBV infection. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2006;23:402-405.
8. Liu PT, et al. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. Journal of Immunology 2007;179:2060-2063.
9. O'Connor KA, et al. Antibiotic prescribing policy and Clostridium difficile diarrhoea. Quarterly Journal of Medicine 2004;97:423-429.
10. Gravel D, et al. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clinical Infectious Diseases 2009;48:568-576.
11. Bujanda L, Cosme A. Clostridium difficile-associated diarrhea. Journal of Gastroenterology and Hepatology 2009;32:48-56.
12. Dubberke ER, Wertheimer AI. Review of current literature on the economic burden of Clostridium difficile infection. Infection Control and Hospital Epidemiology 2009;30:57-66.
13. Noskin GA, et al. Budget impact analysis of rapid screening for Staphylococcus aureus colonization among patients undergoing elective surgery in US hospitals. Infection Control and Hospital Epidemiology 2008;29:16-24.
14. Engemann JJ, et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infection Control and Hospital Epidemiology 2005;26:534-539.
15. Rubin RJ, et al. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerging Infectious Diseases 1999;5:9-17.
16. Peiris AN, Bailey BA, Manning T. The relationship of vitamin D deficiency to health care costs in veterans. Military Medicine 2008;173:1214-1218.
17. Napier RH, et al. Insurance billing and coding. Dental Clinics of North America 2008;52:507-27, viii.
18. Bodnar LM, Krohn MA, Simhan HN. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. Journal of Nutrition 2009;139:1157-1161.
19. Nasri H, Baradaran A. The influence of serum 25-hydroxy vitamin D levels on Helicobacter pylori infections in patients with end-stage renal failure on regular hemodialysis. Saudi Journal of Kidney Diseases and Transplantation 2007;18:215-219.
20. Haug C, et al. Subnormal serum concentration of 1, 25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival. Journal of Infectious Diseases 1994;169:889-893.
21. Ginde AA, Mansbach JM, Camargo Jr. CA. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine 2009;169:384-390.
22. Wayse V, et al. Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. European Journal of Clinical Nutrition 2004;58:563-567.
23. Li-Ng M, et al. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiology and Infection 2009;137:1396-1404.
24. Leandro AC, et al. Genetic polymorphisms in vitamin D receptor, vitamin D-binding protein, Toll-like receptor 2, nitric oxide synthase 2, and interferon-gamma genes and its association with susceptibility to tuberculosis. Brazilian Journal of Medical and Biological Research 2009;42:312-322.
25. Wilbur AK, et al. Vitamin D receptor gene polymorphisms and susceptibility M. tuberculosis in native Paraguayans. Tuberculosis (Edinburgh) 2007;87:329-337.
26. Huff GR, et al. Effect of dietary supplementation with vitamin D metabolites in an experimental model of turkey osteomyelitis complex. Poultry Science 2002;81:958-965.
27. Silva ME, et al. Vitamin D overload and experimental Trypanosoma cruzi infection: parasitological and histopathological aspects. Comparative Biochemistry and Physiology 1993;104:175-181.
28. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1, 25-dihydroxyvitamin D3. FASEB Journal 2005;19:1067-1077.
29. Leventis P, Kiely PD. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scandinavian Journal of Rheumatology 2009;38:149-153.
30. Doll R, Hill AB. Smoking and carcinoma of the lung. Preliminary report. 1950. Bulletin of the World Health Organization 1999;77:84-93.
31. Scragg R, Khaw KT, Murphy S. Life-style factors associated with winter serum 25-hydroxyvitamin D levels in elderly adults. Age and Ageing 1995;24:271-275.
32. Sedrani SH. Low 25-hydroxyvitamin D and normal serum calcium concentrations in Saudi Arabia: Riyadh region. Annals of Nutrition and Metabolism 1984;28:181-185.
33. Jeng L, et al. Alterations in vitamin D status and antimicrobial peptide levels in patients in the intensive care unit with sepsis. Journal of Translational Medicine 2009;7:28.
34. Ginde AA, Liu MC, Camargo Jr. CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Archives of Internal Medicine 2009;169:626-632.
35. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Archives of Internal Medicine 2007;167:1730-1737.
36. Grant WB, et al. Estimated benefit of increased vitamin D status in reducing the economic burden of disease in Western Europe. Progress in Biophysics and Molecular Biology 2009;99:104-113.